Farallon Capital Management

Portfolio Companies 2026 for Farallon Capital Management: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Farallon Capital Management accounts for 20 tracked companies with verified cap-table data, 20 of which disclose round sizes totalling $7.7B. The median disclosed raise is $240M, and the largest is AUTO1 Group at $1.4B, ahead of Isemia ($820M) and Garena ($722M).

The names that recur most often on these portfolio cap tables are Farallon Capital Management (20 companies), Point72 (4 companies), Logos Capital (4 companies), Surveyor Capital (4 companies), OrbiMed (3 companies), Boxer Capital (3 companies). By latest disclosed round, the market skews IPO (4), Series D (4), Growth (3), Series B (3).

Best funded Farallon Capital Management companies

  1. AUTO1 Group — $1.4B (latest: IPO)
  2. Isemia — $820M (latest: Growth)
  3. Garena — $722M (latest: Series E)
  4. Mirador Therapeutics — $650M (latest: Series B)
  5. Point Biopharma — $650M (latest: IPO)
  6. EGenesis — $481M (latest: Series D)
  7. Alvotech — $475M (latest: Growth)
  8. Prometheus Biosciences — $400M (latest: Series A)
  9. Metagenomi — $300M (latest: Series B)
  10. Encoded Therapeutics — $240M (latest: Series D)
  11. Tango Therapeutics — $225M (latest: Series A)
  12. VelosBio — $213M (latest: Seed)
  13. Affinia Therapeutics — $210M (latest: Series B)
  14. Minerva Neuroscience — $200M (latest: Growth)
  15. Pentera — $190M (latest: Series D)

Farallon Capital Management, L.L.C. — related firms and companies (56)

Farallon Capital Management, L.L.C. profile · All research reports